Weng, Dong <br/><br/>
Azithromycin treats diffuse panbronchiolitis by targeting T cells via inhibition of mTOR pathway.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Feb 2019 
 - 440-448 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2018.11.090  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Bacterial Agents--pharmacology<br/>Azithromycin--pharmacology<br/>Bronchiolitis--drug therapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Haemophilus Infections--drug therapy<br/>Humans<br/>Jurkat Cells<br/>Male<br/>Middle Aged<br/>Signal Transduction--drug effects<br/>T-Lymphocytes--drug effects<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors